226 related articles for article (PubMed ID: 20055128)
1. [Advances in the study of affinity selection-ultrafiltration/HPLC-MS].
Zhao HY; Zhang YZ; Xiao CL
Yao Xue Xue Bao; 2009 Oct; 44(10):1084-8. PubMed ID: 20055128
[TBL] [Abstract][Full Text] [Related]
2. Applications of pulsed ultrafiltration-mass spectrometry.
Johnson BM; Nikolic D; van Breemen RB
Mass Spectrom Rev; 2002; 21(2):76-86. PubMed ID: 12373745
[TBL] [Abstract][Full Text] [Related]
3. Affinity selection-mass spectrometry screening techniques for small molecule drug discovery.
Annis DA; Nickbarg E; Yang X; Ziebell MR; Whitehurst CE
Curr Opin Chem Biol; 2007 Oct; 11(5):518-26. PubMed ID: 17931956
[TBL] [Abstract][Full Text] [Related]
4. Measurements of drug-protein binding by using immobilized human serum albumin liquid chromatography-mass spectrometry.
Cheng Y; Ho E; Subramanyam B; Tseng JL
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Sep; 809(1):67-73. PubMed ID: 15282095
[TBL] [Abstract][Full Text] [Related]
5. Drug screening of pharmaceutical discovery compounds by micro-size exclusion chromatography/mass spectrometry.
Wabnitz PA; Loo JA
Rapid Commun Mass Spectrom; 2002; 16(2):85-91. PubMed ID: 11754252
[TBL] [Abstract][Full Text] [Related]
6. Advances in high-throughput high-performance liquid chromatography and "purification-friendly" combinatorial library design strategies.
Schefzick S
Adv Chromatogr; 2007; 45():197-213. PubMed ID: 17626560
[No Abstract] [Full Text] [Related]
7. Method for quantitative protein-ligand affinity measurements in compound mixtures.
Annis DA; Shipps GW; Deng Y; Popovici-Müller J; Siddiqui MA; Curran PJ; Gowen M; Windsor WT
Anal Chem; 2007 Jun; 79(12):4538-42. PubMed ID: 17500537
[TBL] [Abstract][Full Text] [Related]
8. GPC spin column HPLC-ESI-MS methods for screening drugs noncovalently bound to proteins.
Siegel MM
Methods Mol Biol; 2009; 572():231-45. PubMed ID: 20694696
[TBL] [Abstract][Full Text] [Related]
9. Current and future trends in the application of HPLC-MS to metabolite-identification studies.
Castro-Perez JM
Drug Discov Today; 2007 Mar; 12(5-6):249-56. PubMed ID: 17331890
[TBL] [Abstract][Full Text] [Related]
10. Pharmaceutical applications of affinity-ultrafiltration mass spectrometry: Recent advances and future prospects.
Wei H; Zhang X; Tian X; Wu G
J Pharm Biomed Anal; 2016 Nov; 131():444-453. PubMed ID: 27668554
[TBL] [Abstract][Full Text] [Related]
11. Mass spectrometric techniques for label-free high-throughput screening in drug discovery.
Roddy TP; Horvath CR; Stout SJ; Kenney KL; Ho PI; Zhang JH; Vickers C; Kaushik V; Hubbard B; Wang YK
Anal Chem; 2007 Nov; 79(21):8207-13. PubMed ID: 17902631
[TBL] [Abstract][Full Text] [Related]
12. Two-dimensional liquid chromatography/mass spectrometry set-up for structural elucidation of metabolites in complex biological matrices.
Kiffe M; Graf D; Trunzer M
Rapid Commun Mass Spectrom; 2007; 21(6):961-70. PubMed ID: 17299833
[TBL] [Abstract][Full Text] [Related]
13. Native MS: an 'ESI' way to support structure- and fragment-based drug discovery.
Vivat Hannah V; Atmanene C; Zeyer D; Van Dorsselaer A; Sanglier-Cianférani S
Future Med Chem; 2010 Jan; 2(1):35-50. PubMed ID: 21426045
[TBL] [Abstract][Full Text] [Related]
14. Discovery and characterization of orthosteric and allosteric muscarinic M2 acetylcholine receptor ligands by affinity selection-mass spectrometry.
Whitehurst CE; Nazef N; Annis DA; Hou Y; Murphy DM; Spacciapoli P; Yao Z; Ziebell MR; Cheng CC; Shipps GW; Felsch JS; Lau D; Nash HM
J Biomol Screen; 2006 Mar; 11(2):194-207. PubMed ID: 16490772
[TBL] [Abstract][Full Text] [Related]
15. Development of a new approach for screening combinatorial libraries using MALDI-TOF-MS and HPLC-ESI-MS/MS.
Mathur S; Hassel M; Steiner F; Hollemeyer K; Hartmann RW
J Biomol Screen; 2003 Apr; 8(2):136-48. PubMed ID: 12844434
[TBL] [Abstract][Full Text] [Related]
16. Automatic mass spectrometry method development for drug discovery: application in metabolic stability assays.
Chovan LE; Black-Schaefer C; Dandliker PJ; Lau YY
Rapid Commun Mass Spectrom; 2004; 18(24):3105-12. PubMed ID: 15565734
[TBL] [Abstract][Full Text] [Related]
17. Liquid chromatography-mass spectrometry in in vitro drug metabolite screening.
Tolonen A; Turpeinen M; Pelkonen O
Drug Discov Today; 2009 Feb; 14(3-4):120-33. PubMed ID: 19059358
[TBL] [Abstract][Full Text] [Related]
18. Analysis and screening of combinatorial libraries using mass spectrometry.
Shin YG; van Breemen RB
Biopharm Drug Dispos; 2001; 22(7-8):353-72. PubMed ID: 11835254
[TBL] [Abstract][Full Text] [Related]
19. Immobilized magnetic beads-based multi-target affinity selection coupled with HPLC-MS for screening active compounds from traditional Chinese medicine and natural products.
Chen Y; Chen Z; Wang Y
Methods Mol Biol; 2015; 1286():121-9. PubMed ID: 25749951
[TBL] [Abstract][Full Text] [Related]
20. Affinity selection-mass spectrometry for the discovery of pharmacologically active compounds from combinatorial libraries and natural products.
Muchiri RN; van Breemen RB
J Mass Spectrom; 2021; 56(5):e4647. PubMed ID: 32955158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
